Singapore markets close in 5 hours 11 minutes
Straits Times Index
3,166.32 -21.34 (-0.67%) Nikkei
36,818.81 -1,260.89 (-3.31%) Hang Seng
16,159.28 -226.59 (-1.38%) FTSE 100
7,877.05 +29.06 (+0.37%) Bitcoin USD
61,713.27 -298.25 (-0.48%) CMC Crypto 200
1,278.88 +393.35 (+42.84%)
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.65B |
| Enterprise value | 4.31B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.39 |
| Price/book (mrq) | 83.61 |
| Enterprise value/revenue | 1.80 |
| Enterprise value/EBITDA | 10.79 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.35 |
| 52-week change 3 | 228.83% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 6.46 |
| 52-week low 3 | 1.58 |
| 50-day moving average 3 | 5.71 |
| 200-day moving average 3 | 4.68 |
Share statistics
| Avg vol (3-month) 3 | 1.5M |
| Avg vol (10-day) 3 | 1.53M |
| Shares outstanding 5 | 308.55M |
| Implied shares outstanding 6 | 308.55M |
| Float 8 | 123.43M |
| % held by insiders 1 | 59.78% |
| % held by institutions 1 | 29.04% |
| Shares short (28 Mar 2024) 4 | 2.4M |
| Short ratio (28 Mar 2024) 4 | 1.3 |
| Short % of float (28 Mar 2024) 4 | 0.93% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.78% |
| Shares short (prior month 29 Feb 2024) 4 | 1.83M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -3.51% |
| Operating margin (ttm) | 13.19% |
Management effectiveness
| Return on assets (ttm) | 4.66% |
| Return on equity (ttm) | -36.06% |
Income statement
| Revenue (ttm) | 2.39B |
| Revenue per share (ttm) | 13.59 |
| Quarterly revenue growth (yoy) | 1.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 500.78M |
| Net income avi to common (ttm) | -83.99M |
| Diluted EPS (ttm) | -0.48 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 93.74M |
| Total cash per share (mrq) | 0.31 |
| Total debt (mrq) | 2.75B |
| Total debt/equity (mrq) | 4,486.69% |
| Current ratio (mrq) | 1.63 |
| Book value per share (mrq) | 0.06 |
Cash flow statement
| Operating cash flow (ttm) | 345.58M |
| Levered free cash flow (ttm) | 303.9M |
© 2024 Yahoo. All rights reserved.